cytena: Cellink to Acquire cytena, for €30.25M

Cellink AB (Nasdaq First North: CLNK), a Swedish 3D bioprinter provider, is to acquire cytena GmbH, a German life science company focusing on single-cell technologies, for €30.25M. The acquisition strengthens Cellink's product offering and providing a more complete 3D cell culturing solution. Founded in 2014 within the Institute for Microsystems Technology (IMTEK) at the University [...]The post Cellink to Acquire cytena, for €30.25M appeared first on FinSMEs.